Hemangioma is a well-recognized cause of airway obstruction in the infant with stridor. Corticosteroid and laser therapy are effective in stabilizing the airway in most cases. There are, however, some extensive airway lesions that are not adequately managed by these modalities. This report describes the use of recombinant interferon alfa-2a in 15 patients with life-threatening airway hemangiomas. All patients had failed corticosteroid and/or laser therapy. Multiple upper airway sites were involved, including the base of the tongue, supraglottis, subglottis, trachea, and mediastinum. Eleven patients have completed therapy and are doing well. Four patients have resolving lesions on the drug regimen. Life-threatening airway lesions unresponsive to conventional treatment should be considered for a trial of interferon alfa-2a.
HealyGMcGillTFriedmanEM. Carbon dioxide laser in subglottic hemangioma. An update. Ann Otol Rhinol Laryngol1984; 93: 370–3.
15.
ShikhaniAHJonesMMMarshBRHollidayMJ. Infantile subglottic hemangiomas. An update. Ann Otol Rhinol Laryngol1986; 95: 336–47.
16.
BrodskyLYoshpeNRubenRJ. Clinical-pathological correlates of congenital subglottic hemangiomas. Ann Otol Rhinol Laryngol1983; 92(suppl 105): 4–18.
17.
EdgertonMT. The treatment of hemangiomas: With special reference to the role of steroid therapy. Ann Surg1976; 183: 517–32.
18.
EnjolrasORicheMCMerlandJJEscandeJP. Management of alarming hemangiomas in infancy: A review of 25 cases. Pediatrics1990; 85: 491–8.
19.
MeeuwisJBosCEHoeveLJvan der VoortE. Subglottic hemangiomas in infants: Treatment with intralesional corticosteroid injection and intubation. Int J Pediatr Otorhinolaryngol1990; 19: 145–50.
20.
HealyGBFearonBFrenchRMcGillT. Treatment of subglottic hemangioma with the carbon dioxide laser. Laryngoscope1980; 90: 809–13.
21.
MizonoGDedoHH. Subglottic hemangiomas in infants: Treatment with CO2 laser. Laryngoscope1984; 94: 638–41.
22.
CottonRTTewfikTL. Laryngeal stenosis following carbon dioxide laser in subglottic hemangioma. Report of three cases. Ann Otol Rhinol Laryngol1985; 94: 494–7.
23.
RobertsonJSWiegandDASchaitkinBM. Life-threatening hemangioma arising from the parotid gland. Otolaryngol Head Neck Surg1991; 104: 858–62.
24.
WeberTRConnorsRHTracyTFBaileyPV. Complex hemangiomas of infants and children. Arch Surg1990; 125: 1017–20.
25.
WhiteCWSondheimerHMCrouchECWilsonHFanLL. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med1989; 320: 1197–200.
26.
OrchardPJSmithCMWoodsWGDayDLDehnerLPShapiroR. Treatment of haemangioendotheliomas with alpha interferon. Lancet1989; 2: 1565–7.
27.
WhiteCWWolfSJKoronesDNSondheimerHMTosiMFYuA. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr1991; 118: 59–66.
28.
Brouty-BoyeDZetterBR. Inhibition of cell motility by interferon. Science1980; 208: 516–8.
FolkmanJ. Successful treatment of an angiogenic disease. N Engl J Med1989; 320: 1211–2.
31.
MullikenJBGlowackiJ. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg1982; 69: 412–20.
